Allergan, Inc. (NYSE:AGN)

Allergan, Newell Brands Topple into Thursday’s 52-Week Low Club

October 19, 2017: Here are four stocks trading with heavy volume among 13 equities making new 52-week lows in Thursday's session. On the NYSE, decliners led advancers by about 8 ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Adobe, Allergan, Amex, Baker Hughes, Nike, Northern Dynasty, Sprint, Wayfair and More

Stocks have hit new highs and the Dow Jones Industrial Average blew through 23,000 this week as easily as a knife cutting through butter. Thursday morning was indicated to be ...
Read Full Story »

Wednesday’s Biggest Winners and Losers in the S&P 500

October 18, 2017: The S&P 500 closed relatively flat at 2,561.24. The DJIA closed up 0.69% at 23,156.84. Separately, the Nasdaq was relatively flat at 6,624.22. Wednesday was a positive day for ...
Read Full Story »

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. The firm is looking at pharma and biotech opportunities around politics, drug pipelines and ...
Read Full Story »

4 UBS Top Pick Growth Stocks to Buy for the Rest of 2017

With the fourth quarter starting next week, and the final three months of 2017 upon us, many of the top firms that we cover on Wall Street are making some ...
Read Full Story »

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Altria, Apple, Discovery, DowDuPont, JPMorgan, Red Hat, T-Mobile and More

Stocks were indicated marginally higher on Tuesday morning. Despite three days of selling, the markets did just hit all-time highs again last week. The primary trend that has dominated this eight-year bull ...
Read Full Story »

10 Companies with the Biggest 2016 Share Buybacks

As the U.S. economy clawed its way back from the depths of the financial crisis, the stock market recovered too, only more quickly. Partly that was because of public companies' ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CenterPoint, NetApp, NiSource, Nvidia, Orbital ATK, Weyerhaeuser and More

Stocks were indicated to open strong on Monday, with the Dow up almost 100 points and the S&P 500 up about 13 points. Even with the market being just under ...
Read Full Story »

Is Editas Facing a New Reality in CRISPR Land?

Editas Medicine Inc. (NASDAQ: EDIT) is one of the biotech and biohealth players that sits on the cusp of new technology and developments for the next major growth phase in ...
Read Full Story »

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse analyst Vamil Divan has released an outlook on the pharmaceutical sector. While the weighting for the sector is Market Weight, there are some positives in the call. The ...
Read Full Story »

JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017

One segment in the markets that has been dogged with issues for almost two years is the big pharmaceuticals, as numerous factors have kept the lid on share prices and, ...
Read Full Story »

4 UBS Large Cap Top Pick Dividend Growth Stocks to Buy Now

One of the disturbing trends about the ongoing market rally is that a small number of huge stocks are responsible for much of the gains, and that is reminiscent of the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Costco, Domino’s Pizza, Fortinet, Verizon, Yum Brands and More

After a huge Thursday in which the markets soared, the futures traded flat to modestly higher Friday morning. With earnings still coming in hot and heavy, many on Wall Street are ...
Read Full Story »

Huge Real Estate and Health Care Trades Highlight Insider Selling: Regency Centers, Allegan, UnitedHealthcare, Wyndham and More

In a week that offered up almost everything, and was completed by another outstanding nonfarm payroll report, the insider activity that had been heavily leaning toward the sellers started to ...
Read Full Story »